Yayınlanmış 1 Ocak 2018
| Sürüm v1
Dergi makalesi
Açık
Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas
Oluşturanlar
- 1. Acibadem Univ, Sch Med, Dept Med Biol, Istanbul, Turkey
- 2. Acibadem Univ, Dept Med Engn, Fac Engn, Istanbul, Turkey
- 3. Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA
- 4. Acibadem Univ, Sch Med, Dept Med Stat & Bioinformat, Istanbul, Turkey
- 5. Acibadem Univ, Sch Med, Dept Neurosurg, Inonu Cad Okur Sok 20 Kozyatagi, TR-34742 Istanbul, Turkey
- 6. Acibadem Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey
- 7. Acibadem Univ, Sch Med, Dept Pathol, Istanbul, Turkey
- 8. Acibadem Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Istanbul, Turkey
Açıklama
OBJECTIVE Recent studies have established that hemispheric diffuse gliomas may be grouped into subsets on the basis of molecular markers; these subsets are loosely correlated with the histopathological diagnosis but are strong predictors of clinical tumor behavior. Based on an analysis of molecular and clinical parameters, the authors hypothesized that mutations of the telomerase promoter (TERTp-mut) mark separate oncogenic programs among isocitrate dehydrogenase 1 and/or 2 (IDH) mutant (IDH-mut) and IDH wild-type (IDH-wt) diffuse gliomas independent of histopathology or WHO grade.
Dosyalar
bib-541a63c1-5d6a-4f8c-95b6-6eec8c8ebb69.txt
Dosyalar
(380 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:07ada7f3638a523a5d69d8fc613f1adf
|
380 Bytes | Ön İzleme İndir |